Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia	Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypogammaglobulinemia, Hypogammaglobulinemia, Acquired, Neoplasms by Histologic Type, agammaglobulinemia, cardiovascular disorder, common variable immunodeficiency, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, inborn error of immunity, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Phase 2	2026-10-05		NCT06976476

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Memorial Sloan Kettering Cancer Center	753

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Emory University (Data Collection Only)	Atlanta	United States	5
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)	Basking Ridge	United States	3
Memorial Sloan Kettering Bergen (All Protocol Activities)	Montvale	United States	82
Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York	United States	230
Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown	United States	92
Memorial Sloan Kettering Nassau (All Protocol Activities)	Uniondale	United States	53
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity)	Commack	United States	2
Memorial Sloan Kettering Westchester (All Protocol Activities)	Harrison	United States	86
Mount Sinai Hospital	New York	United States	225